Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
ROPIVACAINE HYDROCHLORIDE INJECTION USP PFIZER CANADA ULC Actual shortage 10MG Updated Report 2022-05-25 158396
SALOFALK APTALIS PHARMA CANADA ULC Anticipated shortage 1G New Report 2022-05-25 161258
PROSTIN VR STERILE SOLUTION PFIZER CANADA ULC Resolved 500MCG Updated Report 2022-05-25 154147
KALETRA ABBVIE CORPORATION Actual shortage 100MG 400MG Updated Report 2022-05-25 159917
MYLAN-CLOBETASOL CREAM MYLAN PHARMACEUTICALS ULC Resolved 0.05% Updated Report 2022-05-25 160856
MYLAN-NAPROXEN/ESOMEPRAZOLE MR MYLAN PHARMACEUTICALS ULC Actual shortage 20MG 500MG Updated Report 2022-05-25 152651
MYLAN-TADALAFIL MYLAN PHARMACEUTICALS ULC Actual shortage 20MG Updated Report 2022-05-25 152654
MYLAN-VARDENAFIL MYLAN PHARMACEUTICALS ULC Actual shortage 10MG Updated Report 2022-05-25 157908
MYLAN-ATOVAQUONE/PROGUANIL MYLAN PHARMACEUTICALS ULC Anticipated shortage 100MG 250MG New Report 2022-05-25 161243
PROTAMINE SULFATE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 10MG Updated Report 2022-05-25 156322

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
SANDOZ METHYLPHENIDATE SR SANDOZ CANADA INCORPORATED Discontinued 20MG New Report 2022-05-24 161221
SANDOZ TOPIRAMATE TABLETS SANDOZ CANADA INCORPORATED Discontinued 200MG New Report 2022-05-24 161216
SANDOZ TOPIRAMATE TABLETS SANDOZ CANADA INCORPORATED Discontinued 100MG New Report 2022-05-24 161211
SANDOZ TOPIRAMATE TABLETS SANDOZ CANADA INCORPORATED Discontinued 25MG New Report 2022-05-24 161206
IMOVANE SANOFI-AVENTIS CANADA INC To be discontinued 5.0MG Updated Report 2022-05-16 160688